Leukemia Research
Volume 30, Issue 12 , Pages 1585-1586 , December 2006

Antibodies contained in “M” component of some patients with multiple myeloma are directed to food antigens?

  • Zorica Juranić

      Affiliations

    • Institute for Oncology and Radiology of Serbia, Belgrade, Serbia and Montenegro
    • Corresponding Author InformationCorresponding author at: Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia and Montenegro. Tel.: +381 112067290.
    • ,
  • Jelena Radic

      Affiliations

    • Institute for Oncology and Radiology of Serbia, Belgrade, Serbia and Montenegro
    • ,
  • Aleksandra Konic-Ristic

      Affiliations

    • Institute for Oncology and Radiology of Serbia, Belgrade, Serbia and Montenegro
    • ,
  • Svetislav Jelic

      Affiliations

    • Institute for Oncology and Radiology of Serbia, Belgrade, Serbia and Montenegro
    • ,
  • Biljana Mihaljevic

      Affiliations

    • School of Medicine, University of Belgrade, Belgrade, Serbia and Montenegro
    • ,
  • Irina Besu

      Affiliations

    • Institute for Oncology and Radiology of Serbia, Belgrade, Serbia and Montenegro

Received 26 January 2006

References 

  1. Chen-Kiang S. Biology of plasma cells. Best Practice Res Clin Haematol. 2005;18:493–507
  2. Dispenzieri A, Kyle RA. Multiple myeloma: clinical features and indications for therapy. Best Practice Res Clin Haematol. 2005;18:553–568
  3. Merlini G, Farhangi M, Osserman EF. Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias. Semin Oncol. 1986;13:350–365
  4. Palova-Jelinkova L, Rozkova D, Pecharova B, Bartova J, Sediva A, Tlaskalova-Hogenova H, et al. Gliadin fragments induce phenotypic and functional maturation of human dendritic cells. J Immunol. 2005;175:7038–7045
  5. Romaldini CC, Barbieri D, Okay TS, Raiz R, Cancado EL. Serum soluble interleukin-2 receptor, interleukin-6, and tumor necrosis factor-alpha levels in children with celiac disease: response to treatment. J Pediatr Gastroenterol Nutr. 2002;35(4):513–517
  6. Tučková L, Karská K, Walters JRF, Michalak M, Rossmann P, Krupičková S, et al. Antigliadin antibodies in patients with celiac disease cross-react with enterocytes and human calreticulin. Clin Immunol Immunopathol. 1997;85:289–296
  7. Sánchez D, Tučková L, Šebo P, Michalak M, Whelan A, Šterzl I, et al. Occurrence of IgA and IgG autoantibodies to calreticulin in coeliac disease and various autoimmune diseases. J Autoimmun. 2000;15:441–449
  8. Krupickova S, Tuckova L, Flegelova Z, Michalak M, Walters JRF, Whelan A, et al. Identification of common epitopes on gliadin, enterocytes, and calreticulin recognised by antigliadin antibodies of patients with coeliac disease. Gut. 1999;44:168–173
  9. Tursi A, Brandimarte G, Giorgetti GM. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol. 2003;98:839–843

PII: S0145-2126(06)00049-X

doi: 10.1016/j.leukres.2006.01.013

Leukemia Research
Volume 30, Issue 12 , Pages 1585-1586 , December 2006

Article Tools